Abstract

PMS25 - Switching of Biological Drugs in Rheumatoid Arthritis: A Cohort of Users from the Brazilian Public Health System

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The perplexity of prescribing and switching of biologic drugs in rheumatoid arthritis: a UK regional audit of practice.
Tim Blake ... Nicola Erb
BMC Musculoskeletal Disorders | VOL. 15
Tim Blake, et. al.Tim Blake ... Nicola Erb
02 Sep 2014
Response measures influence comparative effectiveness of biological drugs in rheumatoid arthritis
Helena Canhao ... Fernando Martins
Journal of Translational Medicine | VOL. 10
Helena Canhao, et. al.Helena Canhao ... Fernando Martins
01 Nov 2012
A novel multi-biomarker combination predicting relapse from long-term remission after discontinuation of biological drugs in rheumatoid arthritis
Katsuya Nagatani ... Eiji Sakashita
Scientific Reports | VOL. 11
Katsuya Nagatani, et. al.Katsuya Nagatani ... Eiji Sakashita
21 Oct 2021
Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison.
Petra Baji ... Márta Péntek
The European journal of health economics : HEPAC : health economics in prevention and care | VOL. Suppl 15 1
Petra Baji, et. al.Petra Baji ... Márta Péntek
01 May 2014
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
How many Monte Carlo samples are needed for probabilistic cost-effectiveness analyses?
Reza Yaesoubi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Reza YaesoubiReza Yaesoubi
06 Jul 2024
Three Pillars of Support for Orphan Drug Programs: Individual Valuations, Societal Valuations, and Anonymous Altruism
Darius N Lakdawalla ... Hong-Hanh Nguyen
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Darius N Lakdawalla, et. al.Darius N Lakdawalla ... Hong-Hanh Nguyen
06 Jul 2024
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
EQ-5D-5L population scores in mainland China: results from a nationally representative survey 2021
Qiang Yao ... Chaojie Liu
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Qiang Yao, et. al.Qiang Yao ... Chaojie Liu
06 Jul 2024
View more papers